Nektar soars today on J.P. Morgan healthcare conference
Anybody still think that conferences, especially biotech conferences, don’t move stock prices? Shares of Nektar Therapeutics (NKTR) are up 7.65% today to $61.79 as of noon New York time on the company’s appearance at this week’s J.P. Morgan biotech...
Why a portfolio of “passive” ETFs requires active management by you–announcing my new ETF portfolio to do just that
Can I clear up one bit of confusion? ETFs are indeed passively managed investment vehicles. Their portfolios passively follow indexes rather than allocating money into the picks of a fund manager. But portfolios of ETFs put together by investors aren’t–and...
Here’s what I’ve been writing about on my paid sites: Biotech stocks dipping just before medical meeting schedule gets heavy
Let me share a post about a trading opportunity that I put up today on my paid sites. Yes, that’s sites. Plural. I’ve been busy building a second site, JugglingWithKnives.com, that parallels the focus of my book Juggling With Knives on volatility. If you...
On my paid sites: Long-term options trade on Facebook and Apple
It’s been quite a while since I shared with you what I’ve been thinking and writing about on my paid sites. Yes, that’s sites. Plural. Which explains why I haven’t filled you in since July. I’ve been busy building a second site,...Jim’s Daily Email Alerts:
Every post from Jubak Picks straight to your mailbox. And they're free!